Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Promyelocytic, Acute 1Leukemia, Myeloid, Acute 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 3Busulfan 3Tacrolimus 2Peripheral Blood Stem Cell Transplantation 2Methotrexate 2Filgrastim 2Arsenic Trioxide 2tamibarotene 1fludarabine phosphate 1Tretinoin 1Mycophenolic Acid 1Idarubicin 1Clofarabine 1Bortezomib 1Antilymphocyte Serum 1Alemtuzumab 1AEG 35156 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Leukemia, Promyelocytic, Acute × tamibarotene × Clear all
NCT00985530 2013-10-30

Tamibarotene and Arsenic Trioxide for Relapsed Acute Promyelocytic Leukemia

Northwestern University

Phase 1 Terminated
4 enrolled
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡